At-risk patient and healthcare provider perspectives on clinical trial participation for ductal carcinoma in situ.

被引：0
|
作者：
Adams, Elizabeth
Kulkarni, Swati
Zheng, Veronica
Warwar, Samantha Ahsan
Brown, Denisha
Schulte, Lauren
Cooper, Robin
Labomascus, Bazil
Bhavsar, Erica B.
机构：
[1] Northwestern Univ Feinberg Sch Med, Chicago, IL USA
[2] Northwestern Mem Hosp, Dept Surg, Chicago, IL USA
[3] Northwestern Univ, Chicago, IL USA
[4] Robin Cooper Res Grp Inc, Winter Garden, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10539
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The successful patient-preference design for the LORD-trial to test whether active surveillance for low-risk Ductal Carcinoma In Situ is safe
    Schmitz, R.
    Sondermeijer, C.
    Van der Noort, V.
    Engelhardt, E.
    Gerritsma, M.
    Verschuur, E.
    Van Oirsouw, M.
    Bleiker, E.
    Bijker, N.
    Mann, R.
    Van Duijnhoven, F.
    Wesseling, J.
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : S3 - S4
  • [42] Recording Patient Assessment for Clinical Trial Participation: A Study of Radiation Oncologists Across a Single Healthcare System
    Mackay, C.
    Gurley-Calvez, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E438 - E438
  • [43] RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation
    McCormick, Beryl
    Winter, Kathryn
    Hudis, Clifford
    Kuerer, Henry Mark
    Rakovitch, Eileen
    Smith, Barbara L.
    Sneige, Nour
    Moughan, Jennifer
    Shah, Amit
    Germain, Isabelle
    Hartford, Alan C.
    Rashtian, Afshin
    Walker, Eleanor M.
    Yuen, Albert
    Strom, Eric A.
    Wilcox, Jeannette L.
    Vallow, Laura A.
    Small, William, Jr.
    Pu, Anthony T.
    Kerlin, Kevin
    White, Julia
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07) : 709 - 715
  • [44] Prospective Study of Patient, Nursing, and Oncology Provider Perspectives on Telemedicine Visits for Renal Cell Carcinoma Clinical Trials
    Doshi, Sahil D.
    Knezevic, Andrea
    Gonzalez, Carlene
    Fischer, Patricia
    Goodman, Robert
    Gornell, Suzanne
    Patel, Sweta
    Puzio, Cindy
    Ritea, Alisa
    Lee, Chung-Han
    Evans, Lauren
    Voss, Martin H.
    Motzer, Robert J.
    Kotecha, Ritesh R.
    CLINICAL GENITOURINARY CANCER, 2025, 23 (01)
  • [45] Patient/Provider Discussions About Clinical Trial Participation and Reasons for Nonparticipation Among Adolescent and Young Adult Women with Cancer
    Anderson, Chelsea
    Smitherman, Andrew B.
    Meernik, Clare
    Edwards, Teresa P.
    Deal, Allison M.
    Cannizzaro, Nancy
    Baggett, Christopher D.
    Chao, Chun
    Nichols, Hazel B.
    JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 2020, 9 (01) : 41 - 46
  • [46] Do Clinical and Pathologic Features of Ductal Carcinoma In Situ (DCIS) Vary with Patient Age? An Analysis of 657 Patients
    Collins, L.
    Schnitt, S.
    Achacoso, N.
    Fletcher, S.
    Nekhlyudov, L.
    Haque, R.
    Quesenberry, C.
    Habel, L.
    LABORATORY INVESTIGATION, 2009, 89 : 35A - 35A
  • [47] Do Clinical and Pathologic Features of Ductal Carcinoma In Situ (DCIS) Vary with Patient Age? An Analysis of 657 Patients
    Collins, L.
    Schnitt, S.
    Achacoso, N.
    Fletcher, S.
    Nekhlyudov, L.
    Haque, R.
    Quesenberry, C.
    Habel, L.
    MODERN PATHOLOGY, 2009, 22 : 35A - 35A
  • [48] Improving well-being for individuals with persistent pain after surgery for breast cancer, lobular carcinoma in situ, or ductal carcinoma in situ: A randomized clinical trial
    Stalls, Juliann M.
    Bovbjerg, Dana H.
    Somers, Tamara J.
    Vilardaga, Jennifer C. Plumb
    Kimmick, Gretchen G.
    McAuliffe, Priscilla F.
    Keefe, Francis J.
    Posluszny, Donna M.
    Sullivan, Michael J. L.
    Erkanli, Alaattin
    Reed, Shelby D.
    Sutton, Linda
    Owen, Lynda
    Massa, Lisa
    Shelby, Rebecca A.
    CONTEMPORARY CLINICAL TRIALS, 2022, 122
  • [49] Risk perception of patients with ductal carcinoma in situ (DCIS) of the breast and their healthcare practitioners: The importance of histopathological terminology, and the gaps in our knowledge
    Riggi, Julia
    Galant, Christine
    Vernaeve, Hilde
    Vassilieff, Maud
    Berliere, Martine
    Van Bockstal, Mieke R.
    HISTOLOGY AND HISTOPATHOLOGY, 2025, 40 (03) : 297 - 306
  • [50] Clinical Outcomes of Conservative Treatment for Low-Risk Ductal Carcinoma in Situ: A Systematic Review and Pooled Analysis
    Co, M.
    Cheng, K. C. K.
    Yeung, Y. H.
    Lau, K. C.
    Qian, Z.
    Wong, C. M.
    Wong, B. Y.
    Sin, E. L. K.
    Wong, H. Y. S.
    Ma, C. H.
    CLINICAL ONCOLOGY, 2023, 35 (04) : 255 - 261
12345